Clear Cell Carcinoma of Endometrium

1979 ◽  
Vol 65 (2) ◽  
pp. 201-205 ◽  
Author(s):  
Silvestro G. Carinelli ◽  
Francomaria Senzani
Keyword(s):  
Cell Carcinoma ◽  
Endometrial Carcinoma ◽  
Sex Hormones ◽  
Clear Cell ◽  
Clear Cell Carcinoma ◽  
Endometrial Adenocarcinoma

Three cases of clear cell carcinoma of the endometrium are here reported. Clear cell carcinoma is a rare and aggressive type of endometrial adenocarcinoma. Patients are older and are in the menopause much longer than are patients with typical endometrial carcinoma. This fact may reflect the presence of counterbalanced sex hormones in the process of carcinogenesis.

A Rare Case of Endometrial Adenocarcinoma with Renal Clear Cell Carcinoma

2016 ◽  
Vol 4 (1) ◽  
pp. 56-59
Author(s):  
Prashanthi Damodharan ◽  
Usha Vishwanath ◽  
Priyanka Mehta ◽  
S Gouthaman ◽  
K Sriram
Keyword(s):  
Cell Carcinoma ◽  
Rare Case ◽  
Clear Cell ◽  
Clear Cell Carcinoma ◽  
Endometrial Adenocarcinoma ◽  
Renal Clear Cell Carcinoma

scholarly journals A Rare Case of Endometrial Adenocarcinoma with Renal Clear Cell Carcinoma

2018 ◽  
Vol 6 (2) ◽  
pp. 135-138
Author(s):  
K Sriram ◽  
Priyanka Mehta ◽  
Usha Vishwanath ◽  
Prashanthi Damodharan ◽  
S Gouthaman
Keyword(s):  
Cell Carcinoma ◽  
Rare Case ◽  
Clear Cell ◽  
Clear Cell Carcinoma ◽  
Endometrial Adenocarcinoma ◽  
Renal Clear Cell Carcinoma

Pembrolizumab as adjuvant therapy in a patient with Lynch syndrome with synchronous mixed clear cell carcinoma of ovarian origin and endometroid endometrial carcinoma

2021 ◽  
Vol 14 (11) ◽  
pp. e245497
Author(s):  
Kathleen Batty ◽  
Minmin Li ◽  
Sally Baron-Hay
Keyword(s):  
Lynch Syndrome ◽  
Cell Carcinoma ◽  
Endometrial Carcinoma ◽  
Clear Cell ◽  
Clear Cell Carcinoma ◽  
Total Abdominal Hysterectomy ◽  
Complete Response ◽  
Abdominal Hysterectomy ◽  
High Index Of Suspicion ◽  
Percutaneous Thrombectomy

A 48-year-old woman was diagnosed with synchronous mixed clear cell carcinoma of ovarian origin and endometroid endometrial carcinoma after presenting with intermenstrual bleeding for 2 years prior. Shortly after diagnosis she became progressively unwell requiring intensive care unit admission with respiratory failure, pleural effusions and pulmonary emboli. Following a total abdominal hysterectomy, bilateral salpingo-oophorectomy, laparotomy and emergency percutaneous thrombectomy, she remained critically unwell and was deemed not safe for chemotherapy. Given a high index of suspicion for Lynch syndrome, the patient was treated with adjuvant pembrolizumab and achieved a complete response. Lynch syndrome was subsequently confirmed through germline genetic testing. The patient made an excellent recovery and remains disease-free at 23 months.

Should Endometrial Clear Cell Carcinoma be Classified as Type II Endometrial Carcinoma?

2015 ◽  
Vol 34 (1) ◽  
pp. 74-84 ◽  
Author(s):  
Hyo Sook Bae ◽  
Hyesun Kim ◽  
Sun Young Kwon ◽  
Kyu-Rae Kim ◽  
Jae Yun Song ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Endometrial Carcinoma ◽  
Clear Cell ◽  
Clear Cell Carcinoma ◽  
Type Ii

Delayed Pancreatic Metastasis of Renal Clear Cell Carcinoma

2013 ◽  
Vol 13 (2) ◽  
pp. 79-80
Author(s):  
Zane Simtniece ◽  
Gatis Kirsakmens ◽  
Ilze Strumfa ◽  
Andrejs Vanags ◽  
Maris Pavars ◽  
...  
Keyword(s):  
Abdominal Pain ◽  
Surgical Treatment ◽  
Cell Carcinoma ◽  
Clear Cell ◽  
Clear Cell Carcinoma ◽  
Primary Tumour ◽  
Renal Clear Cell Carcinoma ◽  
Pancreatic Metastasis ◽  
Distal Pancreatic Resection

Abstract Here, we report surgical treatment of a patient presenting with pancreatic metastasis (MTS) of renal clear cell carcinoma (RCC) 11 years after nephrectomy. RCC is one of few cancers that metastasise in pancreas. Jaundice, abdominal pain or gastrointestinal bleeding can develop; however, asymptomatic MTS can be discovered by follow-up after removal of the primary tumour. The patient, 67-year-old female was radiologically diagnosed with a clinically silent mass in the pancreatic body and underwent distal pancreatic resection. The postoperative period was smooth. Four months after the surgery, there were no signs of disease progression.

Sign in / Sign up

Export Citation Format

Share Document